News
15h
Zacks Investment Research on MSNWhy Eli Lilly (LLY) is a Top Growth Stock for the Long-TermTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
ADI shares flashed a Golden Cross pattern on July 1, when the 50-day moving average crossed above the 200-day, a classic ...
4d
Zacks Investment Research on MSNBrokers Suggest Investing in Lilly (LLY): Read This Before Placing a BetThe recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.
Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
Eli Lilly’s stock closed at $771.75, slipping 3.45% and lagging the broader market. The company’s shares fell despite ...
NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new ...
Ahead of posting its second-quarter results, Netflix (NFLX) closed at $1,274.17. In post-market trade, markets did not react to the strong results and increase in the company’s fiscal year revenue ...
Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results